股票 › MDXG
美迈德生物 MDXG
美股市值排名 #3671
$3.31 +$0.03 (+0.91%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $3.31 0.00%
开盘$3.25
昨收$3.28
当日区间$3.23 – $3.39
成交量1.11M
市值$483.01M
市盈率（TTM）–
股息率–
MDXG 相关新闻
匹配 MiMedx 或代码 MDXG 的头条新闻，按最新排序。
- Craig-Hallum Maintains MiMedx(MDXG.US) With Buy Rating, Announces Target Price $8
- Lake Street Maintains MiMedx(MDXG.US) With Buy Rating, Cuts Target Price to $5 负面
- Lake Street Maintains MiMedx(MDXG.US) With Buy Rating, Raises Target Price to $7 正面
- A Quick Look at Today's Ratings for MiMedx(MDXG.US), With a Forecast Between $5 to $8
- Citizens JMP Maintains MiMedx(MDXG.US) With Buy Rating, Cuts Target Price to $6 负面
- Citizens JMP Maintains MiMedx(MDXG.US) With Buy Rating, Cuts Target Price to $7 负面
- Craig-Hallum Maintains MiMedx(MDXG.US) With Buy Rating, Announces Target Price $7
- Northland Securities Maintains MiMedx(MDXG.US) With Buy Rating, Cuts Target Price to $6 负面
- Mizuho Securities Maintains MiMedx(MDXG.US) With Buy Rating, Maintains Target Price $10
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Agilon Health (AGL), MiMedx Group (MDXG) and Park Dental Partners, Inc. (PARK)
- Lake Street Maintains MiMedx(MDXG.US) With Buy Rating, Maintains Target Price $10
- Northland Securities Maintains MiMedx(MDXG.US) With Buy Rating, Maintains Target Price $10
- Citizens JMP Initiates MiMedx(MDXG.US) With Buy Rating, Announces Target Price $10
- Mizuho Securities Maintains MiMedx(MDXG.US) With Buy Rating, Cuts Target Price to $7 负面
- Craig-Hallum Maintains MiMedx(MDXG.US) With Buy Rating, Announces Target Price $7
暂无评论——快来第一个聊聊 MDXG。
登录后参与讨论。